Tony S.K. Mok, Benjamin J. Solomon, Enriqueta Felip, Todd Michael Bauer, Geoffrey Liu, Yasushi Goto, Yi-Long Wu, Ross Andrew Soo, Julien Mazières, Filippo de Marinis, Dong-Wan Kim, I-Ming Wang, Jolanda Paolini, Anna Polli, Nada Rifi, Francesca Toffalorio, Alice Tsang Shaw. "Lorlatinib vs crizotinib as first-line treatment for advanced
                    <i>ALK</i>
                    + non-small cell lung cancer: 7-year update from the phase 3 CROWN study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8502